Omeros (OMER) Shares Outstanding (Diluted Average) (2019 - 2026)

Omeros' (OMER) quarterly Shares Outstanding (Diluted Average) came in at $90.1 million in Q1 2026, up 55.22% year-on-year from $58.1 million in Q1 2025, and up 55.22% quarter-over-quarter from $58.1 million in Q1 2025.

Omeros (OMER) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends

Omeros has disclosed Shares Outstanding (Diluted Average) across 7 years of filings, most recently posting $90.1 million for Q1 2026.

  • Shares Outstanding (Diluted Average) for Q1 2026 came in at $90.1 million, up 55.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $90.1 million (up 55.22% YoY), and the FY2022 annual result was $62.7 million, up 0.63% from the prior year.
  • Shares Outstanding (Diluted Average) came in at $90.1 million for Q1 2026 at Omeros, up from $58.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $90.1 million in Q1 2026 to a low of $58.1 million in Q1 2025.
  • The 4-year median for Shares Outstanding (Diluted Average) is $62.7 million (2022), against an average of $65.6 million.
  • Across the five-year window, Shares Outstanding (Diluted Average) climbed 0.17% in 2023 and jumped 55.22% in 2026, its largest moves.
  • Omeros' Shares Outstanding (Diluted Average) stood at $62.7 million in 2022, then advanced by 0.16% to $62.8 million in 2023, then slipped by 7.61% to $58.1 million in 2025, then surged by 55.22% to $90.1 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $90.1 million (Q1 2026), $58.1 million (Q1 2025), and $62.8 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 4,489.46 Bn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 810.00
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 118.76 Bn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 256.30 Mn
9 Abivax 90.15 Bn 90.15 Bn - 92.44 Mn
10 Omeros 628.56 Mn 493.24 Mn 9.31 Mn 90.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.12 Mn
Mar 31, 2025 58.06 Mn
Jun 30, 2023 62.84 Mn
Mar 31, 2023 62.83 Mn
Dec 31, 2022 62.74 Mn
Sep 30, 2022 62.73 Mn
Jun 30, 2022 62.73 Mn
Mar 31, 2022 62.72 Mn
Dec 31, 2021 62.34 Mn
Sep 30, 2021 62.51 Mn
Jun 30, 2021 62.37 Mn
Mar 31, 2021 61.93 Mn
Dec 31, 2020 57.18 Mn
Sep 30, 2020 55.68 Mn
Jun 30, 2020 54.41 Mn
Dec 31, 2019 49.52 Mn